Federico Grossi, Chief Medical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 2,500 shares at $48.79 ($122K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $122k APLS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2022-10-05 | $167K | — | Filing → |
| APLS | SELL | 2022-09-02 | $151K | — | Filing → |
| APLS | SELL | 2022-08-02 | $140K | — | Filing → |